Clinical Trial Update: Safety, Tolerability, Pharmacokinetics (PK), and Food Effect of MK-7762 in Healthy Adults [Phase 1]

View source ↗

Summary

A Phase 1 study reports on the safety, tolerability, pharmacokinetics, and food effect of the experimental TB drug MK-7762 in healthy adults.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Tuberculosis

Drugs mentioned

• MK-7762 (MK-7762)

Snippet

Sponsor: Gates Medical Research Institute | Conditions: Tuberculosis | Phase 1 | Status: COMPLETED